Common variation in the MOG gene influences transcript splicing in humans

Area of Science:

• Neuroimmunology
• Genetics
• Molecular Biology

Background:

• Multiple sclerosis (MS) is an autoimmune disease affecting the central nervous system (CNS).
• Myelin oligodendrocyte glycoprotein (MOG) is implicated in MS pathogenesis.
• Genetic susceptibility to MS is linked to variations in the MOG gene.

Purpose of the Study:

• To investigate the association between MOG gene variations and MOG expression in post-mortem human brain tissue.
• To determine if specific MOG gene variants influence MOG splicing or expression levels relevant to MS.

Main Methods:

• Quantitative reverse transcriptase PCR (qPCR) to assess MOG splicing and expression.
• Predictive algorithms to analyze the effect of MOG variants on splicing enhancers.
• SNaPshot® method to evaluate allele-specific expression.

Main Results:

• The MOG haplotype with the 520A allele (rs3130253A) showed a 1.7-fold increase in exon 2 to exon 3 splicing.
• The 520G>A variant was predicted to alter an exonic splicing enhancer (ESE) involving SC35 and SRp55.
• No consistent differences in allele-specific MOG expression were observed for the studied single nucleotide polymorphisms (SNPs).

Conclusions:

• Common genetic variations in the MOG gene are associated with altered MOG splicing, but not expression levels, in MS brain tissue.
• The observed changes in MOG splicing may play a role in MS pathophysiology.
• Further research is needed to confirm these findings and their relevance to MS, especially in populations like Northern Europeans.